Janux Therapeutics Inc.

NASDAQ: JANX · Real-Time Price · USD
25.04
0.07 (0.28%)
At close: Aug 15, 2025, 3:59 PM
25.11
0.30%
After-hours: Aug 15, 2025, 04:34 PM EDT

Janux Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-33.86M -23.51M -20.22M -28.06M -5.96M -14.76M -11.76M -11.57M -17.51M -17.46M -16.07M -16.7M -16.89M -13.41M -13.42M -10.77M -6.21M -2.28M
Depreciation & Amortization
541K 519K 512K 510K 506K 532K 531K 500K 471K 453K 403K 249K 108K 81K 64K 27K 13K 9K
Stock-Based Compensation
10.96M 10.7M 6.25M 15.39M 5.76M 5.63M 4.48M 4.55M 5.5M 5.47M 4.21M 4.6M 4.44M 3.96M 2.94M 2.57M 1.28M 123K
Other Working Capital
2.64M 1.12M -1.9M 11.65M 323K -3.47M -1.42M -3.31M -1.51M 157K 113K 339K 5.5M -1.39M 467K -787K -946K -4K
Other Non-Cash Items
-5.21M -4.22M -2.93M -1.87M -2.97M -1.79M -2.06M -2.11M -1.84M -1.68M -1.29M -768K -99K -24K 13.43M -79K -32K -7.83M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -13.49M n/a n/a n/a
Change in Working Capital
3.75M -516K -345K 11.8M -7.35M -4.45M -1.1M -3.08M -1.68M -700K 836K -795K 6.36M -2.13M -15K 2.4M -1.26M 7.71M
Operating Cash Flow
-23.81M -17.02M -16.73M -2.23M -10.02M -14.84M -9.9M -11.71M -15.05M -13.91M -11.91M -13.41M -6.07M -11.52M -10.48M -5.85M -6.2M 5.56M
Capital Expenditures
-473K -371K -42K -25K -95K -197K -515K -470K -580K -285K -2.06M -2.52M -898K -971K -1.17M -77K -79K -153K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -11.64M 60.98M -18.45M 8.46M n/a -22.28M -9.94M n/a -120.37M n/a n/a n/a
Purchase of Investments
-92.69M -371.29M -24.03M -32.47M -235.54M -178.54M -33.11M -135.98M -76.55M -71.7M -86.05M -94.47M -68.81M -45.06M -103.5M -227.61M -142.52M n/a
Sales Maturities Of Investments
94.72M 31.27M 58M 45.16M 44.75M 65M 44.75M 75M 95M 63.25M 86.5M 116.75M 78.75M 77.1M 112M 22.14M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 11.64M -60.98M 18.45M -8.46M n/a 22.28M 9.94M 32.04M 120.37M 22.14M -142.52M n/a
Investing Cash Flow
1.56M -340.39M 33.93M 12.67M -190.88M -113.74M 11.12M -61.45M 17.87M -8.74M -1.6M 19.76M 9.04M 31.07M 7.33M -205.54M -142.6M -153K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a 1.66M n/a 79K 528K 1.58M 191K n/a 308K 1K 164K n/a 205.11M 1.55M
Financial Cash Flow
954K 554K 386.65M 1.65M 2.77M 322.17M 831K 56.61M 528K 1.58M 191K n/a 308K 1K 164K -843K 329.66M 57.55M
Net Cash Flow
-21.3M -356.86M 403.85M 12.09M -198.14M 193.6M 2.05M -16.55M 3.35M -21.07M -13.33M 6.35M 3.27M 19.55M -2.99M -212.24M 180.86M 62.96M
Free Cash Flow
-24.29M -17.39M -16.77M -2.26M -10.12M -15.03M -10.42M -12.18M -15.63M -14.2M -13.97M -15.93M -6.97M -12.49M -11.65M -5.93M -6.28M 5.41M